Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:27 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 625–648 of 1,131 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Functional MRI Clear all

Conditions: Depression, Treatment Resistant
Interventions: Transcranial magnetic stimulation; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Treatment-refractory Obsessive-compulsive Disorder (trOCD)
Interventions: Radiosurgical anterior capsulotomy; Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Brain Cancer
Interventions: preoperative fMRI. DTI and DSI with tractography; Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Parkinson Disease, Essential Tremor, Dystonia, Obsessive Compulsive Disorder
Interventions: Functional Magnetic Resonance Imaging (fMRI); Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cocaine Dependence
Interventions: Acthrel; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Age Related Cognitive Decline, Alzheimer's Disease, Vascular Dementia, Endothelial Dysfunction, Executive Dysfunction
Interventions: Omega 3 PUFA, Placebo; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 75 Years and older
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Healthy, Schizophrenia
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 55 Years
Enrollment: 1,386 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Healthy
Interventions: Phenytoin (brand name Dilantin), Hydrocortisone, Placebo; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 50 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Obsessive-Compulsive Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 212 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Stanford, California

Conditions: Cannabis Dependence, Cannabis Withdrawal
Interventions: rimonabant, placebo; Drug
Lead sponsor: The Scripps Research Institute; Other
Eligibility: 21 Years to 30 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Stroke, Broca's Aphasia
Interventions: Cortical Electrical Stimulation; Device
Lead sponsor: Northstar Neuroscience; Industry
Eligibility: 21 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Nicotine Dependence
Interventions: Zyban; Drug
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 21 Years to 60 Years
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2011
U.S. locations: 1
States / cities: West Los Angeles, California

Conditions: Pain
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 50 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: OCD, Decision-Making, tDCS, fMRI
Interventions: transcranial Direct Current Stimulation (tDCS); Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 65 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Fibromyalgia
Interventions: Acupuncture, Sham treatment; Device · Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Schizophrenia
Interventions: Targeted cognitive training (TCT), Computer games; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 60 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: HCC - Hepatocellular Carcinoma
Interventions: Yttrium-90 Radiation Segmentectomy (Y90 RS) using glass microspheres; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Schizophrenia
Interventions: Lurasidone 80 mg, Lurasidone 120 mg, Lurasidone 160 mg; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 60 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: Orange, California

Conditions: Depression, Major Depressive Disorder (MDD), Depression - Major Depressive Disorder, Persistent Depressive Disorder, PDD, MDD
Interventions: Active Repetitive Transcranial Magnetic Stimulation (rTMS), Sham Transcranial Magnetic Stimulation (TMS); Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hemiparesis, Ischemic Stroke, Chronic
Interventions: Robot Therapy Device, Occupational Therapy; Device · Behavioral
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 30 Years to 85 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 2
States / cities: Milwaukee, Wisconsin

Conditions: Autism
Interventions: Oxytocin, Placebo; Drug
Lead sponsor: Anagnostou, Evdokia, M.D.; Individual
Eligibility: 18 Years to 50 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes Mellitus, Type 1
Interventions: Observational; Other
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 7 Years to 16 Years
Enrollment: 221 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 5
States / cities: Palo Alto, California • New Haven, Connecticut • Jacksonville, Florida + 2 more

Conditions: Irritable Colon, Irritable Bowel Syndrome (IBS)
Interventions: GW876008 200mcg, GW876008 20mcg, Placebo; Drug · Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Major Depressive Disorder
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 163 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant Depression

Linear Accelerator Radiosurgical Anterior Capsulotomy With Task-based fMRI Identification of PERSonalized and PrEdictiVE Biomarkers of REsponse in Treatment-Refractory Obsessive-Compulsive Disorder (PERSEVERE Trial)

MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning

Functional Magnetic Resonance Imaging (fMRI) During Deep Brain Stimulation (DBS) to Treat Parkinson's Disease

Gender and Neural Substrates of Stress and Craving

n-3 PUFA for Vascular Cognitive Aging

Electrophysiology and Blood Flow in Patients With Schizophrenia and Their Siblings

Phenytoin as a Neuroprotective Agent Against Corticosteroid-induced Functional Imaging Changes

Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCD

Clinical and Neurobiological Effects of Cannabis Dependence in Young Adults

Assessment of Cortical Stimulation Combined With Rehabilitation to Enhance Recovery in Broca's Aphasia.

Brain Reaction to Treatment of Nicotine Dependence

Brain Activation During Accommodation to Painful Stimulation With FMRI

Arbitration Between Habitual and Goal-directed Behavior in Obsessive-compulsive Disorder: Circuit Dynamics and Effects of Noninvasive Neurostimulation

Effectiveness of Acupuncture in Relieving Pain Due to Fibromyalgia

Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With Schizophrenia

Defining the Ablative Dose for Y-90 TARE

A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone

Individualized fMRI-guided TMS for Depression

Functional Magnetic Resonance Imaging (fMRI) and Robot-Assisted Practice of Activities of Daily Living

An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism

Type 1 Diabetes and the Brain in Children

Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers

Brain Regulation of Emotions in People With Depression and Anhedonia